These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 21585327)

  • 1. Patented in vitro blood-brain barrier models in CNS drug discovery.
    Tóth A; Veszelka S; Nakagawa S; Niwa M; Deli MA
    Recent Pat CNS Drug Discov; 2011 May; 6(2):107-18. PubMed ID: 21585327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New experimental models of the blood-brain barrier for CNS drug discovery.
    Kaisar MA; Sajja RK; Prasad S; Abhyankar VV; Liles T; Cucullo L
    Expert Opin Drug Discov; 2017 Jan; 12(1):89-103. PubMed ID: 27782770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human iPSC-Derived Blood-Brain Barrier Models: Valuable Tools for Preclinical Drug Discovery and Development?
    Appelt-Menzel A; Oerter S; Mathew S; Haferkamp U; Hartmann C; Jung M; Neuhaus W; Pless O
    Curr Protoc Stem Cell Biol; 2020 Dec; 55(1):e122. PubMed ID: 32956578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease.
    Di Marco A; Gonzalez Paz O; Fini I; Vignone D; Cellucci A; Battista MR; Auciello G; Orsatti L; Zini M; Monteagudo E; Khetarpal V; Rose M; Dominguez C; Herbst T; Toledo-Sherman L; Summa V; Muñoz-Sanjuán I
    Mol Pharm; 2019 May; 16(5):2069-2082. PubMed ID: 30916978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.
    Stanimirovic DB; Bani-Yaghoub M; Perkins M; Haqqani AS
    Expert Opin Drug Discov; 2015 Feb; 10(2):141-55. PubMed ID: 25388782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier.
    Gumbleton M; Audus KL
    J Pharm Sci; 2001 Nov; 90(11):1681-98. PubMed ID: 11745727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in brain penetration evaluation in drug discovery and development.
    Liu X; Chen C; Smith BJ
    J Pharmacol Exp Ther; 2008 May; 325(2):349-56. PubMed ID: 18203948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Improved In Vitro Porcine Blood-Brain Barrier Model for Permeability Screening and Functional Studies.
    Patabendige A
    Methods Mol Biol; 2022; 2492():131-142. PubMed ID: 35733042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development.
    Ohtsuki S; Terasaki T
    Pharm Res; 2007 Sep; 24(9):1745-58. PubMed ID: 17619998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Blood-Brain Barrier Models Using Primary Parkinson's Disease Rat Brain Endothelial Cells and Astrocytes for the Development of Central Nervous System Drug Delivery Systems.
    Cai P; Zheng Y; Sun Y; Zhang C; Zhang Q; Liu Q
    ACS Chem Neurosci; 2021 Oct; 12(20):3829-3837. PubMed ID: 34623131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models.
    Hellinger E; Veszelka S; Tóth AE; Walter F; Kittel A; Bakk ML; Tihanyi K; Háda V; Nakagawa S; Duy TD; Niwa M; Deli MA; Vastag M
    Eur J Pharm Biopharm; 2012 Oct; 82(2):340-51. PubMed ID: 22906709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a Rat Primary Cell-Based Blood-Brain Barrier Model With Epithelial and Brain Endothelial Cell Lines: Gene Expression and Drug Transport.
    Veszelka S; Tóth A; Walter FR; Tóth AE; Gróf I; Mészáros M; Bocsik A; Hellinger É; Vastag M; Rákhely G; Deli MA
    Front Mol Neurosci; 2018; 11():166. PubMed ID: 29872378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models of the blood-brain barrier using iPSC-derived cells.
    Delsing L; Herland A; Falk A; Hicks R; Synnergren J; Zetterberg H
    Mol Cell Neurosci; 2020 Sep; 107():103533. PubMed ID: 32717317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A co-culture-based model of human blood-brain barrier: application to active transport of indinavir and in vivo-in vitro correlation.
    Megard I; Garrigues A; Orlowski S; Jorajuria S; Clayette P; Ezan E; Mabondzo A
    Brain Res; 2002 Feb; 927(2):153-67. PubMed ID: 11821009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration.
    Heymans M; Sevin E; Gosselet F; Lundquist S; Culot M
    Eur J Pharm Biopharm; 2018 Jun; 127():453-461. PubMed ID: 29602020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier structure and function and the challenges for CNS drug delivery.
    Abbott NJ
    J Inherit Metab Dis; 2013 May; 36(3):437-49. PubMed ID: 23609350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demystifying brain penetration in central nervous system drug discovery. Miniperspective.
    Di L; Rong H; Feng B
    J Med Chem; 2013 Jan; 56(1):2-12. PubMed ID: 23075026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions.
    Roux F; Couraud PO
    Cell Mol Neurobiol; 2005 Feb; 25(1):41-58. PubMed ID: 15962508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening.
    Wang YI; Abaci HE; Shuler ML
    Biotechnol Bioeng; 2017 Jan; 114(1):184-194. PubMed ID: 27399645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current State and Future Perspectives in QSAR Models to Predict Blood- Brain Barrier Penetration in Central Nervous System Drug R&D.
    Morales JF; Montoto SS; Fagiolino P; Ruiz ME
    Mini Rev Med Chem; 2017; 17(3):247-257. PubMed ID: 27739359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.